The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Epidemiological Investigation Of The Role Of Early Life Environment In The Development Of Immune Function And Allergic And Autoimmune Disease: Knowledge Generation For Future Primary Prevention.
Funder
National Health and Medical Research Council
Funding Amount
$664,584.00
Summary
Immune diseases, which include allergic and autoimmune diseases, are accounting for an increasing fraction of the disease burden in Australia. It is now increasingly recognised that early life changes to the immune system by environmental factors can impact on the risk of these diseases. The goal of this fellowship is the prevention of allergic and autoimmune disease.
Interfacing Epidemiology With Systems Biology For Disease Prevention
Funder
National Health and Medical Research Council
Funding Amount
$687,975.00
Summary
Over recent time, allergic and some autoimmune diseases have increased among modern children. The change has been too rapid to be due to genetic factors alone and my research program examines also the role of the changing environment. It also examines the health effects of new man-made exposures like plastic product chemicals.
Sun Exposure, Vitamin D And Photohealth Over The Lifetime
Funder
National Health and Medical Research Council
Funding Amount
$622,655.00
Summary
Australia is a sunny country with a diverse population. Inappropriate sun exposure for skin type leads to skin cancer (mainly in the fair-skinned) and vitamin D deficiency (particularly in the darker-skinned). Potential benefits of sun exposure are broader than vitamin D production, but remain ill-defined. There are few data on appropriate sun exposure for children. This research fellowship builds the evidence to guide sun exposure messages.
Fall Prevention In Older People And Those With Neurodegenerative Disorders
Funder
National Health and Medical Research Council
Funding Amount
$938,910.00
Summary
Falls are a major heath care problem for older people and clinical groups. This program of research will improve fall risk assessments and design and evaluate promising strategies for improving balance control and preventing falls in these groups.
To Understand The Roles Of Plasminogen Activation In The Blood And The Brain
Funder
National Health and Medical Research Council
Funding Amount
$714,745.00
Summary
This research Fellowship will focus of the molecular and cellular biology of the plasminogen activating system, more commonly associated with the removal of blood clots. The research proposed will address a new paradigm for the removal of blood clots, and also a program to understand how the plasminogen activating system modulates the central nervous system and the immune response. This research will impact directly on ischaemic stroke, traumatic brain injury and multiple sclerosis.
Understanding Determinant Selection In Autoimmune Diseases
Funder
National Health and Medical Research Council
Funding Amount
$686,656.00
Summary
Understanding what the immune system perceives during infection or in autoimmunity is key to the development of improved vaccines and therapies for a variety of human diseases. This proposal builds on leading research into the definition of targets of immunity in autoimmune diseases using cutting edge proteomic technologies. The proposal focuses on type 1 diabetes, multiple sclerosis, lupus and rheumatoid arthritis and will delineate candidate therapeutic molecules.
I am the leading scientist studying a factor named BAFF and discovered its role in autoimmunity. BAFF inhibitors are effective in late stage clinical trials treating lupus patients. Our new work shows that BAFF has other fascinating roles, in particular the ability to control effects from some microbes capable of activating autoimmune and inflammatory reactions. This new work is leading us to the development of an entirely new generation of therapeutics treating autoimmunity and inflammation.
In autoimmune diseases the immune system attacks the body’s own tissues. Although we know that both genetic and environmental factors contribute to the risk of disease, identifying these genes and the environmental factors involved is very difficult. Furthermore, we have almost no idea how these factors interact with each other, something we need to understand in order to predict the risk of disease and reliably identify possible therapies. These are the aims of this fellowship.